Notice: Internet Explorer 11 users may encounter issues loading pages throughout the website. Please turn on IE-11’s compatibility mode while we work to resolve the issue.

>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

October 13, 2014

FDA MedWatch - ICU Medical ConMed Stat2 Flow Controller: Class 1 Recall - Delivers Higher Flow Rate than Intended

Summary:

FDA MedWatch ICU Medical ConMed Stat2 Flow Controller

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Responds to Release of GAO Drug Shortage Report

Friday, December 16, 2011

Recently, the Government Accountability Office (GAO) released a long-awaited report on the crisis of drug shortages.  The report is in response to continuing problems that anesthesiologists and other physicians face as they confront an unprecedented number of drug shortages.

ASA President Jerry Cohen, M.D. offered the following remarks about the report’s release:

“ASA was pleased by the release of the GAO Drug Shortages report and appreciated the opportunity to participate as an expert resource in the production of the report. As anesthesiologists continue to confront unprecedented drug shortages across the country, ASA is proud of our efforts in coordination with members of the Drug Shortage Summit to successfully elevate this critical issue in both Congress and the Administration.  We look forward to thoroughly reviewing the GAO report and its recommendations.”

« Back to Washington Alerts